Bizarre Patents
Vehicular Impact Signaling Device
An apparatus for the deployment of a visible plume to alert other motorists that a proximate motor vehicle has been involved in a collision.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8003693 | Modulation of anxiety through blockade of anandamide hydrolysis Fatty acid amide hydrolase inhibitors of the Formula: are provided wherein X is NH, CH2, O, or S; Q is O or S; Z is O or N; R is an aromatic moiety selected from the group consisting of substituted or unsubstitut... | 08/23/2011 |
| 7357937 | Perfluorocarbon emulsions with non-fluorinated surfactants A stable FC emulsion is described. The FC emulsion of the present invention comprises a continuous FC immiscible hydrophilic liquid phase and a dispersed phase comprising FC suspended as droplets within the continuous phase. The emulsion further comprises an emulsif... | 04/15/2008 |
| 7244703 | Pharmaceutical compositions and methods for peptide treatment Compositions and methods for treating a patient with a pharmaceutically active peptide that combines a pharmaceutically active peptide, a permeation enhancer, and a carrier, are disclosed. ... | 07/17/2007 |
| RE39616 | Aminoindan derivatives This invention is directed to compounds of the following formula: wherein when a is 0, b is 1 or 2; when a is 1, b is 1, m is from 0-3, X is O or S, Y is halogeno, R1 is hydrogen C1-4 alkyl, R2 is... | 05/08/2007 |
| 7208528 | Polyamine analogues as therapeutic and diagnostic agents Novel inhibitors of polyamine transport having inhibition constants two orders of magnitude lower than those of known compounds are disclosed. These polyamine analogues are useful pharmaceutical agents for treating diseases where it is desired to inhibit polyamine t... | 04/24/2007 |
| 7160923 | Polyamine analogues as therapeutic and diagnostic agents Novel inhibitors of polyamine transport having inhibition constants two orders of magnitude lower than those of known compounds are disclosed. These polyamine analogues are useful pharmaceutical agents for treating diseases where it is desired to inhibit polyamine t... | 01/09/2007 |
| 7112561 | Pharmaceutical compositions and methods for insulin treatment Compositions and methods for treating a patient with insulin that combines insulin, a permeation enhancer, and a carrier that maintains an acidic pH, are disclosed. ... | 09/26/2006 |
| 7102008 | Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme The present invention provides compounds of Formula (I): or a stereoisomer or pharmaceutically acceptable salt form thereof, wherein the variables A, R1, R2, R3, R4, Z,... | 09/05/2006 |
| 7064130 | Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders A method of treatment of the human or non-human animal body for treating NO-dependent microcirculation disorders is disclosed, for example microcirculation disorders caused by metabolic diseases, such as elevated levels of homocystin-homocystein inflammatory reactio... | 06/20/2006 |
| 7033578 | Antimycotic nail varnish composition The present invention relates to a composition comprising a) at least one antimycotic agent and b) at least one film forming agent wherein component b) is a derivative of chitosan selected from hydroxyalkylchitosans and carboxyalkylchitosans and its use as a nail va... | 04/25/2006 |
| 7029706 | Composition for the treatment of cutaneous mycosis The inventions relates to the use of silica in the formulation of antifungal composition for the treatment of cutaneous mycoses, and method to manufacture an antifungal powder with boric acid and silica. ... | 04/18/2006 |
| 6980906 | Systems and methods for a navigational device with forced layer switching based on memory constraints Systems, devices and methods are provided for more efficient use of RAM and other resources in connection with a route calculation algorithm which quickly obtains a best or reasonable best path between two locations. The navigational aid device includes forced layer... | 12/27/2005 |
| 6974832 | L-ascorbic acid and pectin composition The invention relates to compositions in the form of a powder or granules containing L-ascorbic acid and/or a pharmaceutically acceptable salt thereof, and pectin in a quantity within the range of about 0.1 to about 10% by weight. ... | 12/13/2005 |
| 6975940 | Systems, functional data, and methods for generating a route Devices, systems, functional data and methods are provided for an improved route generation in navigational enabled devices. In generating the route, the available locations are inspected repetitively and locations adjacent to a last selected location are inserted i... | 12/13/2005 |
| 6972292 | Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors The present invention relates to certain substituted polyketides of formula I, wherein A, B, C, D, E, F and m are as defined herein, pharmaceutical compositions containing said compounds, and the use of said compounds ... | 12/06/2005 |
| 6835386 | Collar containing a novel gel formulation to control arthropod infestation of animals The present invention provides a device, preferably a collar or ear tag, capable of the controlled, sustained release of an effective amount of an active ingredient that can protect an animal against arthropod pests, comprising a reservoir containing a novel gel for... | 12/28/2004 |
| 6794384 | Hydroxylation activated drug release The present invention concerns prodrugs whose aromatic oxidation, particularly their enzymatic aromatic hydroxylation, results in their activation by the release of a drug moiety. It particularly concerns anti-tumor prodrugs and those which are specifically activate... | 09/21/2004 |
| 6737547 | Compositions containing and methods of using N-acyl-1H-aminoindenes The present invention provides novel aminoindenes having the structure: wherein n is 1 or 2, R1 is hydrogen, linear or branched chain C1-C8 alkyl or linear or branched chain C1... | 05/18/2004 |
| 6716875 | Synergistic therapeutic compositions of ACE and renin inhibitors and methods This invention relates to compositions and methods for achieving a therapeutic effect such as lowering blood pressure and treating congestive heart failure in a mammal. More specifically, this invention relates to synergistic compositions comprising amounts of at le... | 04/06/2004 |
| 6645959 | Method for treating postoperative ileus This invention is a method for preventing or treating postoperative ileus comprising administering a vasopressin antagonist such as a compound of Formula (1), where R1, R2, and R3 include hydrogen, halo, alkyl, and alkoxy;... | 11/11/2003 |
| 6538025 | Aminoindan derivatives This invention is directed to compounds of the following formula: ##STR1## wherein when a is 0, b is 1 or 2; when a is 1, b is 1, m is from 0-3, X is O or S, Y is halogeno, R1 is hydrogen C1-4 alkyl, R2 is hydrogen, C... | 03/25/2003 |
| 6524603 | Process and composition for the antiparasitic treatment of the surroundings of animals A pesticidal composition and anti-parasitic treatment using the same, wherein the composition includes, in a combined pesticidally effective amount (a) carbaryl and (b) a compound having the formula ##STR1## wherein: R1 is CN; R2 is ... | 02/25/2003 |
| 6500849 | 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino 1,3-propanediols and related compounds Novel 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols, intermediates and processes for the preparation thereof, and methods of reducing inflammation and cell proliferation, and relieving memory dysfunction, and inhibiting bacterial and fu... | 12/31/2002 |
| 6482446 | Astringent composition and method of use The invention provides for astringent compositions comprising from about 0.1% to about 20% by weight of an astringent and between about 0.1% to 10% by weight of alcohol. The compositions have viscosity values of at least about 5,000 centipoise. The invent... | 11/19/2002 |
| 6448238 | Inhibitors of ଲ-lactamases and uses therefor The invention provides novel non-ଲ-lactam inhibitors of ଲ-lactamases. In particular, the invention provides such inhibitors which are boronic acids of formula (1) which is set forth in the specification. These compounds may be used with ³... | 09/10/2002 |
| 6436421 | Pesticide compositions The present invention relates to pesticide compositions. In particular, the present invention relates to pesticide compositions comprising a pesticide and a redispersible polymer and to a method for controlling agricultural pests by applying to the pest o... | 08/20/2002 |
| 6417174 | Inhibitors of ଲ-lactamases and uses therefor The invention provides novel non-ଲ-lactam inhibitors of ଲ-lactamases. In particular, the invention provides such inhibitors which are boronic acids of formula (1) which is set forth in the specification. These compounds may be used with ³... | 07/09/2002 |
| 6416789 | Synergistic combination of fungicides to protect wood and wood-based products from fungal decay, mold and mildew damage A wood treatment material having a synergistic combination of fungicides including boron-containing compounds, organo-iodine compounds and amine-oxides is provided. This combination is shown to be especially effective in providing resistance to decay, mol... | 07/09/2002 |
| 6346545 | Urethanes, thio and dithio analogues and their use as inhibitors of cholesterol biosynthesis The present invention relates to urethanes and the thio and dithio analogues thereof of general formula ##STR1## wherein m, n, A, X, Y and R1 to R8 are defined as in claim 1, the enantiomers, diastereomers and the salts thereof, part... | 02/12/2002 |
| 6333359 | Regulation of cellular apoptosis using modulators of ଲ-AR receptors The invention concerns the use of 댢-adrenergic modulators for regulating cellular apoptosis.... | 12/25/2001 |
| 6303650 | Aminoindan derivatives This invention is directed to compounds of the following formula ##STR1## wherein when a is O, b is 1 or 2; when a is 1, b is 1, m is from 0-3 X is O or S, Y is halogeno, R1 is hydrogen C1-4 alkyl, R2 is hydrogen, C1-... | 10/16/2001 |
| 6290992 | Foam formulation for termite control and method of application therefor A method of termite control consists of injecting a foam formulation above ground into the walls of a structure infested with termites or other undesirable pests. The inner spaces of affected walls are flooded at and above ground level to ensure that the ... | 09/18/2001 |
| 6121314 | Pharmaceutical composition Non-greasy topical solutions, emulsion gels or lotions comprising as the active agent a compound of formula I ##STR1## and a lower alkanol, and if desired together with a solubilizing agent or an oil phase such as isopropyl myristate are useful deliv... | 09/19/2000 |
| 6080744 | Topical antifungal treatment A topical mycological treatment composition for medical, veterinarian, or dental use contains as active ingredients clotrimazole, ketoconazole, micanazole, nystatin, tolnaftate, propionic acid, sodium propionate, undecelynic acid, and zinc undecelynate. T... | 06/27/2000 |
| 6077865 | Topical antifungal formulation containing tolnaftate An antifungal preparation for topical use is described containing tolnaftate and a quaternary ammonium compound. The formulation contains tolnaftate at a pharmaceutical effective concentration along with a quaternary ammonium compound such as benzalkonium... | 06/20/2000 |
| 6075014 | Inhibitors of ଲ-lactamases and uses therefor The invention provides novel non-ଲ-lactam inhibitors of ଲ-lactamases. In particular, the invention provides such inhibitors which are boronic acids of formula (1) which is set forth in the specification. These compounds may be used with ³... | 06/13/2000 |
| 6024972 | Water-free concentrate of amitraz insecticide and clear pour-on formulations thereof A water-free concentrate comprising, by weight, (a) 3-20% of amitraz insecticide, optionally with other agriculturally active chemicals, for example, a pyrethroid; (b) 30-80% of a nonionic surfactant having an HLB | 02/15/2000 |
| 6005001 | Pharmaceutical composition Non-greasy topical solutions, emulsion gels or lotions comprising as the active agent a compound of formula I ##STR1## and a lower alkanol, and if desired together with a solubilizing agent or an oil phase such as isopropyl myristate are useful deliv... | 12/21/1999 |
| 5985907 | Method for inhibiting growth of methanogens Methods and compositions for decreasing the production of methane in ruminant animals, thereby increasing feed utilization efficiency, are disclosed. The methods employ HMG-CoA reductase inhibitors to selectively inhibit the growth of methane-producing ba... | 11/16/1999 |
| 5977170 | Elevation of HDL cholesterol by 4-[(aminothioxomethyl)hydrazono]-4-arylbutyl carbamates This invention relates to the treatment of atherosclerosis via raising the level of HDL cholesterol by administration of a compound of the formula ##STR1## wherein R1, R2, and R3 are independently hydrogen, C1 ... | 11/02/1999 |
